menu
Autologous Matrix-Induced Chondrogenesis Market Grows As The Demand For Collagen Membranes Operations Are Increasing
Autologous Matrix-Induced Chondrogenesis Market Grows As The Demand For Collagen Membranes  Operations Are Increasing
A new procedure to restore damaged articular cartilage is called autologous matrix-induced chondrogenesis. The bilayer collagen I/III membrane is implemented in a single step using the microfracturing technique, which is then followed by partially autologous fibrin glue.

A biological procedure called Autologous Matrix-Induced Chondrogenesis Market (AMIC) is used to cure damaged articular cartilage. AMIC therapy is carried out in stages. After microfracture surgery, a bi-layer collagen I/III membrane is applied. With the goal of avoiding or delaying partial or total surgery for minor joint replacement (such as a knee replacement), it slows down cartilage deterioration. Chondral lesions in Grade III or IV, ranging in size from 2 cm2 to 8 cm2, are among the indications for AMIC.

The minimally invasive autologous matrix-induced chondrogenesis procedure only requires one step. When combined with microfracturing, it lowers the cost of microfracturing in comparison to other treatment options and conventional microfacturing treatments for chondral and osteochondral lesions. One of the most effective methods for treating damaged articular cartilage is microfracture surgery. Bi-layer collagen membrane is used during these operations for Autologous Matrix-Induced Chondrogenesis Market. Consequently, there are more patients suffering from bone and joint diseases.

Read Morre @ https://cmiorientedreportblog.blogspot.com/2022/08/in-global-autologous-matrix-induced.html